Signup Crypto ETF Stocks News

Oragenics, Inc. to Host Management Update Webinar on May 20, 2025 to Discuss Concussion Treatment Landscape, ONP-002 Clinical Program, and Strategic Vision

Webinar to Feature CEO Janet Huffman, Chief Clinical Officer Dr. Frank Peacock, and Dr. James Kelly, Followed by Live Q&A Webinar to Feature CEO Janet Huffman, Chief Clinical Officer Dr. Frank Peacock, and Dr. James Kelly, Followed by Live ...

Source: www.globenewswire.com
May 12, 2025 | 12:30:00
Category: News

MDWerks' Two Trees Beverage Subsidiary Launches Uplifting Spirits, a New Product Line Focused on Supporting Community and Charitable Causes - MDwerks ( OTC:MDWK )

GREEN COVE SPRINGS, Fla., May 12, 2025 ( GLOBE NEWSWIRE ) -- MDWerks, Inc. ( "MDWerks" or the "Company" ) MDWK, a forward-thinking company leading the charge in the world of sustainable technology, today announced that its award-winning subsidiary, Two Trees Beverage Company ( "Two Trees" ) , ...

Source: www.benzinga.com
May 12, 2025 | 12:30:00
Category: General

NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor

Significant Neurological Expertise to Help Drive Clinical Development Strategy and Growth with New Technologies ...

Source: www.globenewswire.com
May 12, 2025 | 12:30:00
Category: News

CSW Industrials Announces Date for Fiscal Fourth Quarter and Full Year 2025 Earnings Release Conference Call

DALLAS, May 12, 2025 ( GLOBE NEWSWIRE ) -- CSW Industrials, Inc. ( NASDAQ: CSWI ) announced that it will release its earnings results for the fiscal fourth quarter and year ended March 31, 2025, on Thursday, May 22, 2025, before the market opens.

Source: www.globenewswire.com
May 12, 2025 | 12:30:00
Category: News

Skillful Craftsman Education Announces Key Hires for New Business Expansion Initiatives

Shenzhen, China, May 12, 2025 ( GLOBE NEWSWIRE ) -- Skillful Craftsman Education Technology Limited ( "Skillful Craftsman" or the "Company" ) ( NASDAQ: EDTK ) , a pioneering education technology company that offers interactive online learning services, today announced the hiring of two ...

Source: www.globenewswire.com
May 12, 2025 | 12:30:00
Category: News

Freight Technologies to Purchase Additional $1 Million of Official Trump Tokens

-Company issues additional $1 million of convertible notes from existing $20 million facility--Continues advocacy for fair and free trade across the ...

Source: www.globenewswire.com
May 12, 2025 | 12:30:00
Category: News

Brag House, in partnership with Florida Gator Athletics and Learfield's Florida Gators Sports Properties, Launches the Inaugural "Brag Gators Gauntlet" Series Baseball Edition at the University of Florida - A tournament Featuring Fortnite ahead of the Florida vs. Alabama Baseball Game

Innovative digital gaming activation blends Gen Z fandom, school spirit, and college sports through immersive tournament play for the casual gamer Innovative digital gaming activation blends Gen Z fandom, school spirit, and college sports through immersive tournament play for the casual gamer ...

Source: www.globenewswire.com
May 12, 2025 | 12:30:00
Category: News

On Balance | How Trump's erratic tariffs could crash his US car production goals

While levies may prompt some foreign carmakers to start scaling up US-based production, many see a market plagued by uncertainty and risk.

Source: www.scmp.com
May 12, 2025 | 12:30:08
Category: Economy

Top 3 Industrials Stocks That May Explode This Month - MISTRAS Group ( NYSE:MG ) , Energy Recovery ( NASDAQ:ERII )

The most oversold stocks in the industrials sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down.

Source: www.benzinga.com
May 12, 2025 | 12:31:34
Category: Trading

EXCLUSIVE: FDA Clears Lantern Pharma's Planned Phase 1b/2 Trial of LP-184 In Treatment-Resistant Lung Cancer Patients - Lantern Pharma ( NASDAQ:LTRN )

The study will assess safety, preliminary efficacy, and biomarker correlations, potentially paving a path toward accelerated development. The biomarker-focused trial will target high-risk NSCLC subtypes by evaluating LP-184 in combination with Bristol-Myers' drugs.

Source: www.benzinga.com
May 12, 2025 | 12:31:40
Category: General

© Natavest 2025 - 2026